For the quarter ending 2025-09-30, PAPA had -$318,283 decrease in cash & cash equivalents over the period. -$218,283 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Other non-current assets | - | 0 |
| Net income attributable to the companys shareholders | -819,923 | 1,410,277 |
| Depreciation of property, plant and equipment | 197,924 | 397,436 |
| Amortization of right-of-use assets | 239,541 | 574,441 |
| Loss on disposal of property, plant and equipment | 0 | -142,045 |
| Reversal of impairment of property, plant and equipment | 0 | -87,392 |
| Loss on derecognition of rou assets | - | -77,060 |
| Gain on derecognition of rou assets | -77,060 | - |
| Provision for stock obsolescence of inventories | - | 283,214 |
| Allowance for stock obsolescence of inventories | 431,693 | - |
| Deferred income tax | -68,196 | -100,114 |
| Accounts receivable, net | 53,044 | -101,433 |
| Inventories, net | -286,005 | 732,054 |
| Prepayments and other current assets, net | 189,819 | 63,054 |
| Accounts payable | -979,838 | -293,898 |
| Operating lease liabilities | -169,908 | -384,235 |
| Income taxes payable | -335,169 | 329,364 |
| Amounts due to related parties | -630,629 | 1,572,807 |
| Advance from customers | -1,061,941 | 2,445,232 |
| Accrued expenses and other current liabilities | -27,582 | -740,566 |
| Net cash used in operating activities | -78,960 | -3,258,202 |
| Payment for the acquisition of subsidiary | - | 0 |
| Purchase of property, plant and equipment | 139,323 | 253,828 |
| Cash used in investing activities | -139,323 | -253,828 |
| Capital contribution | - | 0 |
| Deferred offering cost | 100,000 | 62,000 |
| Net cash used in financing activities | -100,000 | -62,000 |
| Net decrease in cash and cash equivalents | -318,283 | -3,574,030 |
| Cash and cash equivalents at beginning of period | 1,175,812 | 4,749,842 |
| Cash and cash equivalents at end of period | 857,529 | 1,175,812 |
Papa Medical Inc. (PAPA)
Papa Medical Inc. (PAPA)